Core Viewpoint - Movano Health has received a notice from Nasdaq regarding non-compliance with listing rules due to the failure to file its Form 10-Q for the quarter ended March 31, 2025, which was due on May 15, 2025 [1][2]. Group 1: Compliance and Regulatory Actions - The company has 60 calendar days, until July 21, 2025, to submit a plan to regain compliance with Nasdaq's Listing Rule [2]. - If Nasdaq accepts the compliance plan, the company may have up to 180 additional days, until November 11, 2025, to file the Form 10-Q [2]. Group 2: Company Overview - Movano Health, founded in 2018, is focused on developing healthcare solutions that provide medical-grade data through wearable devices [3]. - The company's devices aim to deliver trusted health data and insights to both consumers and enterprises, enhancing health monitoring and management [4].

PLEASANTON, Calif., May 16, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced today that its Board of Directors has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the Company, to maximize shareholder value.  To support this process, Movano Health's Board of Directors has engaged Aquilo Partners as its financial advisor and K&L Gates LLP as its legal counsel.There can be no assurance that this process ...